Eric L. Cramer
Mr. Cramer is Firm Chairman and Co-Chair of the Firm’s antitrust department. He has a national practice in the field of complex litigation, primarily in the area of antitrust class actions. He is currently co-lead counsel in multiple significant antitrust class actions across the country in a variety of industries and is responsible for winning numerous significant settlements for his clients totaling well over $2 billion. Most recently, he has focused on representing workers claiming that anticompetitive practices have suppressed their pay, including cases on behalf of mixed-martial-arts fighters and chicken growers.
In 2018, he was named Philadelphia antitrust “Lawyer of the Year” by Best Lawyers, and in 2017, he won the American Antitrust Institute’s Antitrust Enforcement Award for Outstanding Antitrust Litigation Achievement in Private Law Practice for his work in Castro v. Sanofi Pasteur Inc., No. 11-cv-07178 (D.N.J.). He has also identified as a top tier antitrust lawyer by Chambers & Partners in Pennsylvania and nationally. Chambers observed that Mr. Cramer is “really a tremendous advocate in the courtroom, with a very good mind and presence.” He has been highlighted annually since 2011 by The Legal 500 as one of the country’s top lawyers in the field of complex antitrust litigation, and repeatedly deemed one of the “Best Lawyers in America,” including in 2018. In 2014 and 2018, Mr. Cramer was selected by Philadelphia Magazine as one of the top 100 lawyers in Philadelphia.
Mr. Cramer is also a frequent speaker at antitrust and litigation related conferences. He was the only Plaintiffs’ lawyer selected to serve on the American Bar Association’s Antitrust Section Transition Report Task Force delivered to the incoming Obama Administration in 2012. He is a Senior Fellow and Vice President of the Board of Directors of the American Antitrust Institute; a past President of COSAL (Committee to Support the Antitrust Laws), a leading industry group; a member of the Advisory Board of the Institute of Consumer Antitrust Studies of the Loyola University Chicago School of Law; and a member of the Board of Directors of Public Justice, a national public interest law firm.
He has written widely in the fields of class certification and antitrust law. Among other writings, Mr. Cramer has co-authored Antitrust, Class Certification, and the Politics of Procedure, 17 George Mason Law Review 4 (2010), which was cited by both the First Circuit in In re Nexium Antitrust Litig., 777 F.3d 9, 27 (1st Cir. 2015), quoting Davis & Cramer, 17 Geo. Mason L. Rev. 969, 984-85 (2010), and the Third Circuit in Behrend v. Comcast Corp., 655 F.3d 182, 200, n.10 (3d Cir. 2011), rev’d on other grounds, 133 S. Ct. 1426 (2013). He has also co-written a number of other pieces, including: Of Vulnerable Monopolists?: Questionable Innovation in the Standard for Class Certification in Antitrust Cases, 41 Rutgers Law Journal 355 (2009-2010); A Questionable New Standard for Class Certification in Antitrust Cases, published in the ABA’s Antitrust Magazine, Vol. 26, No. 1 (Fall 2011); a Chapter of American Antitrust Institute’s Private International Enforcement Handbook (2010), entitled “Who May Pursue a Private Claim?”; and, a chapter of the American Bar Association’s Pharmaceutical Industry Handbook (July 2009), entitled “Assessing Market Power in the Prescription Pharmaceutical Industry.”
Mr. Cramer is a summa cum laude graduate of Princeton University (1989), where he was elected to Phi Beta Kappa. He graduated cum laude from Harvard Law School with a J.D. in 1993.
- Vice President of the Board and Senior Fellow of the American Antitrust Institute
- Vice President of the Board of Public Justice (Formerly Trial Lawyers for Public Justice)
- Member of the Advisory Board of the Institute of Consumer & Antitrust Studies at Loyola University Chicago School of Law
- A frequent speaker at antitrust and pharmaceutical conferences around the country
Business and Community Leadership
Mr. Cramer is active in community affairs, specifically those involving public education:
- Co-founder, and past President of the Board of Trustees of the Independence Charter School, for which he also acted as pro bono litigation counsel
- Member of the Board of the Ayer Condominium Association
- Board Member of the Economy League of Philadelphia
- Former Member of the Board of the Center for Literacy (one of largest non-profit adult literacy organizations in the country)
- Former Chair of the Board of EducationVotersPA, a non-profit organization dedicated to supporting issues concerning public education in Pennsylvania
From Judge Michael M. Baylson, of the U.S. District Court of the Eastern District of Pennsylvania:
[C]ounsel…for direct plaintiffs have done an outstanding job here representing the class, and I thought your briefing was always very on point. I thought the presentation of the very contentious issues on the class action motion was very well done, it was very well briefed, it was well argued.
Transcript of the June 28, 2018 Hearing in In re Domestic Drywall Antitrust Litigation, No. MD-13-2437 at 11:6 – 11.
Prominent Judgments and Settlements
- In re Domestic Drywall Antitrust Litig., 13-md-2437 (E.D. Pa.) (settled in 2018 for over $190 million)
- Castro, et al. v. Sanofi Pasteur Inc., Civil Action No. 2:11-cv-07178-JMV-MAH (D.N.J.) (settled in 2017 for $61.5 million)
- United States ex rel. Dr. Joseph Piacentile v. Amgen Inc., CA No. 04-2511(E.D.N.Y.) (qui tam matter settled in 2015 for an undisclosed amount)
- Marchbanks Truck Service Inc., et al. v. Comdata Network, Inc. et al., No. 07-1078 (E.D. Pa.) (settled in 2014 for $130 million plus valuable prospective relief)
- In re TriCor Antitrust Litig., No. 02‑1512 (D. Del.) (settled in 2009 for $250 million)
- In re Ovcon 35 Antitrust Litigation, MDL No. 1747 (D.D.C.) (Settled in 2008 for $22 million)
- In re Terazosin Hydrochloride Antitrust Litig., MDL No. 1317 (S.D. Fla. 2005) (settled in 2005 for $74.5 million)
- In re Remeron Antitrust Litig., No.03‑0085 (D.N.J. 2003) (Settled in 2005 for $75 million)
- In re Relafen Antitrust Litig., No. 01-12239-WGY (D. Mass. 2003) (Settled in 2004 for $175 million)
- In re Buspirone Antitrust Litig., MDL No. 1410 (S.D.N.Y.) (Settled in 2003 for $220 million)
- In re Cardizem CD Antitrust Litig., MDL No. 1278 (E.D. Mich.) (Settled in 2002 for $110 million)
In the News
- Berger Montague Named Tier 1 Antitrust Law Firm in The Legal 500 United States 2019; Eric L. Cramer, H. Laddie Montague Jr., and Caitlin G. Coslett Win Additional Awards
- 32 Berger Montague Attorneys (More Than Half of the Philadelphia Office) Named 2019 Pennsylvania Super Lawyers and Rising Stars
- Berger Montague’s Antitrust Practice Group, Four Department Co-Chairs Ranked in Chambers USA 2019
- Berger Montague Names Eric L. Cramer New Firm Chairman and Announces Next Phase of Firm's Evolution
- H. Laddie Montague Jr. and Eric L. Cramer Included in Who’s Who Legal: Thought Leaders – Competition 2019
- Plaintiffs in Pending Class Action Lawsuit Against UFC Postpone December Information Session for Proposed Class Members
- Managing Shareholder Eric L. Cramer to Speak at 12th Annual Private Antitrust Enforcement Conference in Washington, D.C.
- Managing Shareholder Eric L. Cramer Named Lawyer of the Year, Six Additional Shareholders Named Best Lawyers
- Long-Running Drywall Price-Fixing Lawsuit Settles for More Than $190 Million
- Berger Montague's Antitrust Practice Group, Notable Practitioners Ranked in the Chambers USA 2018 Guide